AIP
LYRA

Ameritas Investment Partners’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Ameritas Investment Partners’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95
Closed -$599 – 3282
2025
Q1 		$599 Hold
95
– – ﹤0.01% 3120
2024
Q4 		$979 Hold
95
– – ﹤0.01% 3121
2024
Q3 		$1.22K Hold
95
– – ﹤0.01% 3110
2024
Q2 		$1.31K Buy
+95
New +$10.7K ﹤0.01% 3104
2021
Q2 		– Sell
-7
Closed -$4K – 3154
2021
Q1 		$4K Hold
7
– – ﹤0.01% 3029
2020
Q4 		$4K Hold
7
– – ﹤0.01% 3001
2020
Q3 		$4K Hold
7
– – ﹤0.01% 3010
2020
Q2 		$4K Buy
+7
New +$5.12K ﹤0.01% 2994

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameritas Investment Partners's LYRA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2025, closing a stake of 95 shares — an estimated $599 sold.

Ameritas Investment Partners first reported a position in LYRA in Q2 2020 and held it in 8 quarters. The position peaked at $4K in Q1 2021. 30 funds tracked by Wall St. Rank hold LYRA as of Q2 2025.

  • Ameritas Investment Partners reported no remaining LYRA THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 95 LYRA THERAPEUTICS INC shares in Q2 2025, an estimated $599.
  • Ameritas Investment Partners first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 8 quarters.
  • Ameritas Investment Partners's LYRA THERAPEUTICS INC position peaked at $4K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.